You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cisplatin-5FU

Showing 1 - 25 of 8,641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Head and Neck Tumors Trial in Nanjing (Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU)

Recruiting
  • Head and Neck Tumors
  • Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU
  • Nanjing, Jiangsu, China
    Department of Oncology, Drum Tower Hospital, Nanjing University
Feb 24, 2023

Head and Neck Squamous Cell Carcinoma Trial (pembrolizumab+cisplatin + 5-fluorouracil)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • pembrolizumab+cisplatin + 5-FU
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Dec 26, 2022

Temporal Bone Squamous Cell Carcinoma Trial in Guangzhou (Paprizumab combined with cisplatin and 5-FU)

Recruiting
  • Temporal Bone Squamous Cell Carcinoma
  • Paprizumab combined with cisplatin and 5-FU
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 5, 2022

Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
Jul 13, 2022

Head and Neck Squamous Cell Carcinoma Trial in France, Germany, Spain (Cisplatin, 5-Fluorouracile, Docetaxel)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Avignon, France
  • +16 more
Aug 22, 2022

Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Esophageal Cancer
  • (no location specified)
Jul 6, 2023

HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)

Not yet recruiting
  • HPV-Negative Squamous Cell Carcinoma
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023

Metastatic Biliary Tract Cancer Trial in Seoul (Onivyde, 5-FU/LV)

Completed
  • Metastatic Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 22, 2022

Head and Neck Squamous Cell Carcinoma Trial in Tours (Docetaxel, Cisplatin, Fluorouracil)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Tours, France
    Hôpital Bretonneau, Service CORad Pôle Henry S Kaplan
Mar 10, 2022

Gastric Cancer Trial in Wuhan (DC, concurrent chemoradiotherapy with 5-FU/CF, radiation)

Recruiting
  • Gastric Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jan 29, 2022

Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)

Completed
Has Results
  • Bladder Cancer
  • induction cisplatin
  • +13 more
  • Atlanta, Georgia
  • +10 more
May 23, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in Darmstadt (Cetuximab, Cisplatin/Carboplatin, 5-fluorouracil)

Completed
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Darmstadt, Germany
    Research site
Apr 19, 2022

Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma Trial in Philadelphia (Capecitabine,

Active, not recruiting
  • Anal Basaloid Carcinoma
  • +6 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jan 3, 2023

Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial (Pembrolizumab, Cisplatin, Carboplatin)

Active, not recruiting
Has Results
  • Recurrent Head and Neck Cancer
  • Metastatic Head and Neck Cancer
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Sinonasal Carcinoma Trial (drug, procedure, other)

Not yet recruiting
  • Sinonasal Carcinoma
  • (no location specified)
Dec 9, 2021

Nasopharyngeal Carcinoma, TNF, Chemo-radiotherapy Trial (5-fu, Cisplatin, Radiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • (no location specified)
Jun 22, 2022

Urothelial Carcinoma of the Bladder Trial in Washington, Baltimore, Philadelphia (drug, radiation, procedure)

Active, not recruiting
  • Urothelial Carcinoma of the Bladder
  • Washington, District of Columbia
  • +3 more
Dec 2, 2022

Esophageal Cancer Trial in Korea, Republic of (procedure, drug, radiation)

Recruiting
  • Esophageal Cancer
  • Esophagectomy
  • +3 more
  • Goyang-si, Korea, Republic of
  • +8 more
Jan 16, 2023

Neck Cancer Trial in Moscow (Pembrolizumab)

Recruiting
  • Neck Cancer
  • Moscow, Russian Federation
  • +2 more
Sep 21, 2022

Advanced Malignant Tumors Trial in Shanghai (AK104, AK117, Capecitabine tablets)

Recruiting
  • Advanced Malignant Tumors
  • Shanghai, China
    Shanghai Renji Hospital
Aug 9, 2022

Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • 5-Fluorouracil (5-FU)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2021

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Tokyo (Nivolumab, 5-FU, CDDP)

Recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • +3 more
  • Tokyo, Japan
    National Cancer Center Hospital
Apr 5, 2022

ESCC or Esophageal Adenosquamous Carcinoma Trial in Guangzhou (HLX07+HLX10+ Cisplatin+5-FU, HLX07)

Recruiting
  • ESCC or Esophageal Adenosquamous Carcinoma
  • HLX07+HLX10+ Cisplatin+5-FU
  • HLX07
  • Beijing, Beijing, China
  • +16 more
Aug 25, 2022